Literature DB >> 30537510

Immunodivergence in Metastatic Colorectal Cancer.

Carlos E de Andrea1, Kurt A Schalper2, Miguel F Sanmamed3, Ignacio Melero4.   

Abstract

Van den Eynde et al. publish in this issue of Cancer Cell that metastatic colorectal cancer shows marked heterogeneity in T cell infiltration among different lesions and patients. Measurements of T cell infiltration in metastases by immunoscore offer some prognostic information and support immune editing by coevolving adaptive immune responses.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh：

Year:  2018        PMID： 30537510     DOI： 10.1016/j.ccell.2018.11.012

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  10 in total

1.  MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder.

Authors:  Lin Zhu; Xianhui Liu; Weiyu Zhang; Hao Hu; Qi Wang; Kexin Xu
Journal:  BMC Cancer       Date:  2022-05-17       Impact factor: 4.638

2.  GGCT promotes colorectal cancer migration and invasion via epithelial-mesenchymal transition.

Authors:  Qi Huang; Yuanhang Zhou; Yue Li; Zhiwei Liao
Journal:  Oncol Lett       Date:  2020-05-30       Impact factor: 2.967

3.  In the literature: February 2019.

Authors:  Amelia Insa; Valentina Gambardella; Andrés Cervantes
Journal:  ESMO Open       Date:  2019-02-13

4.  SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer.

Authors:  Qin Huo; Zhenwei Li; Lixin Cheng; Fan Yang; Ni Xie
Journal:  Front Oncol       Date:  2020-05-12       Impact factor: 6.244

5.  CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma.

Authors:  Zhihuai Wang; Shuai Chen; Gaochao Wang; Sun Li; Xihu Qin
Journal:  Biomed Res Int       Date:  2021-01-29       Impact factor: 3.411

6.  Ano1 is a Prognostic Biomarker That is Correlated with Immune Infiltration in Colorectal Cancer.

Authors:  Jun Chen; Hongli Wang; Fang Peng; Haiyan Qiao; Linfeng Liu; Liang Wang; Bingbing Shang
Journal:  Int J Gen Med       Date:  2022-02-15

7.  Construction of survival-related co-expression modules and identification of potential prognostic biomarkers of osteosarcoma using WGCNA.

Authors:  Yiying Bian; Jintao Huang; Ziliang Zeng; Hao Yao; Jian Tu; Bo Wang; Yutong Zou; Xianbiao Xie; Jingnan Shen
Journal:  Ann Transl Med       Date:  2022-03

8.  High Expression of RAI14 in Triple-Negative Breast Cancer Participates in Immune Recruitment and Implies Poor Prognosis Through Bioinformatics Analyses.

Authors:  Ranliang Cui; Ting Zhao; Changsen Bai; Ning Ji; Jialei Hua; Li Ren; Yueguo Li
Journal:  Front Pharmacol       Date:  2022-04-01       Impact factor: 5.988

9.  Immunogenomic-Based Analysis of Hierarchical Clustering of Diffuse Large Cell Lymphoma.

Authors:  Longhao Wang; Wei Yuan; Lifeng Li; Zhibo Shen; Qishun Geng; Yuanyuan Zheng; Jie Zhao
Journal:  J Immunol Res       Date:  2022-08-09       Impact factor: 4.493

10.  Combining Immunoscore with Clinicopathologic Features in Cholangiocarcinoma: An Influential Prognostic Nomogram.

Authors:  Xiang-Song Wu; Wei Gong; Zi-You Wu; Wei Shen; Juan-Qing Yue; Wen-Yan Yao; Shi-Lei Liu; Yun-Peng Jin; Ping Dong; Fei Ma
Journal:  Onco Targets Ther       Date:  2020-11-06       Impact factor: 4.147
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.